Global healthcare company GlaxoSmithKline (GSK) is all set to close the tablet-packaging plant at its Boronia site in Melbourne's east, Australia, leading to a loss of 120 jobs. According to GSK, continuing challenges in the operating ...
Tags: GSK, Packaging Plant
GlaxoSmithKline (GSK) and Theravance have announced the FDA approval of Breo Ellipta as maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD) patients. The inhaled long-term, once-daily maintenance ...
Tags: GSK, Theravance, Copd Therapy
GlaxoSmithKline (GSK) has announced the availability of new online system to share patient level data from its clinical trials with researchers as part of its commitment to transparency. The new online system available on gsk.com enables ...
Tags: GSK, Patient Level Data
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases. The funding will move the early-stage research to ...
Tags: Glaxosmithkline, funding injection
GlaxoSmithKline (GSK) has submitted a new drug application (NDA) to the US FDA for umeclidinium bromide (UMEC) monotherapy 62.5mcg to treat chronic obstructive pulmonary disease (COPD). The investigational once-daily UMEC, administered ...
Tags: GlaxoSmithKline, FDA Approval, chronic obstructive pulmonary disease
Avalon Ventures has announced the collaboration with GlaxoSmithKline (GSK) to create 10 life sciences companies in San Diego, US. Avalon will find the technology, provide management and ensures that the companies meet their milestones. ...
Tags: Avalon, GSK Partner
GlaxoSmithKline (GSK) has announced it is to sell its soft drink brands Lucozade and Ribena, in a bid to improve its strategic focus and enhance its growth profile. Lucozade and Ribena are estimated to be for sale for 766M Andrew ...
Tags: GlaxoSmithKline, Food, GSK
GSK and Theravance have announced the submission of a regulatory application for Anoro Ellipta (UMEC/VI) (62.5/25mcg and 125/25mcg doses) in Japan. UMEC/VI combines a long-acting muscarinic antagonist (LAMA) GSK573719 or umeclidinium ...
GlaxoSmithKline (GSK) has received the marketing authorization from Germany's Paul Ehrlich Institut (PEI) and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for its quadrivalent (four-strain) influenza vaccine. ...
Tags: GSK, Strain Influenza Vaccine
The US Food and Drug Administration (FDA) has recommended removing certain warning statements and modifications of the instructions for the use of over-the-counter (OTC) nicotine replacement therapy (NRT) products. Commending FDA ...
Tags: FDA, Nicotine Medications Labeling, Medicine
GlaxoSmithKline (GSK) is closing its Sirtris Pharmaceuticals office in Cambridge and fully integrating its research and development (R&D) operations with Philadelphia office. The firm is mulling to relocate some of the 60 staffers ...
The Cyber Security Challenge (CSC) is not only about recruiting talent, but is aimed at raising awareness and widening the IT security talent pool, according to the competition's CEO, Stephanie Danan. Danan was responding to Computing's ...
Tags: Cyber Security, IT security, cyber
The food industry’s biggest ever takeover was announced over the past month with the sale of Heinz to a consortium led by the sage of Omaha, Warren Buffett, and Brazilian private equity specialist Jorge Lemann’s 3G Capital group ...
The Cyber Security Challenge, a series of national events designed to encourage talented professionals to join the UK IT security industry, has just announced its latest winner, 28-year-old chemist Stephen Miller. Government cyber ...
Tags: Cyber Security Challenge, IT security industry, cyber security
GlaxoSmithKline (GSK) has submitted marketing authorisation application, to the European Medicines Agency, for trametinib (MEK) as monotherapy and dabrafenib (BRAF)/MEK combination therapy in metastatic melanoma. The application was ...
Tags: GSK, metastatic melanoma therapy, Medicines